Transaction #678 · Form 4 · 0001731122-25-001386
Endovia Health Sciences, Inc. · Stock award · Warrants
Endovia Health Sciences, Inc. · Transacted July 31, 2025 · Filed October 15, 2025
What does this filing report?
An SEC Form 4 filing for Endovia Health Sciences, Inc. records a stock award involving Warrants on July 31, 2025. The reported quantity was 750,000. The filing date is October 15, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company CIK
- 0001553788
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 750,000
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 750,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 15, 2025, 4:20 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Nistico Robert ↗
CEO and Chairman · Director · 10% owner
CIK 0001797597
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 750,000
- Conversion / exercise price
- 0.8
- Exercise date
- July 31, 2025
- Expiration date
- July 31, 2030
Filing footnotes & remarks
- F1
- The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants shall vest as follows: one third upon completion of the repayment by the Company of the UpTime Investors and the other two thirds vesting quarterly over a two-year period with the first vesting date on October 31, 2025.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.